Twitter | Search | |
GT Medical Technologies, Inc.
Improving the Lives of Patients with Brain Tumors
37
Tweets
22
Following
48
Followers
Tweets
GT Medical Technologies, Inc. Aug 15
Joan was the first person treated with Therapy in Arizona at . Dr. Wanebo, a surgeon, placed the tiles at the end of the surgery, and radiation therapy started working right away. Read more at the link below.
Reply Retweet Like
GT Medical Technologies, Inc. retweeted
Health+Commerce Aug 15
Via : 's GammaTile Therapy changed the life of this Arizonan, whose brain tumor kept growing back & impacting her vision. She went to to be treated by Dr. John Wanebo & was the first in AZ to receive the therapy.
Reply Retweet Like
GT Medical Technologies, Inc. Aug 12
We would love to have you visit our Tempe HQ to see how an AZ-based start-up is improving treatment outcomes for patients with recurrent brain tumors, including glioblastomas, meningiomas, and metastases!
Reply Retweet Like
GT Medical Technologies, Inc. Jul 31
Dr. Clark Chen, neurosurgeon and Therapy user, explains, “GammaTile is placed right next to the surgical site, where it releases intense, targeted radioactivity... giving the same course of radiation used in the traditional therapy.”
Reply Retweet Like
GT Medical Technologies, Inc. Jul 17
Senator recalls his experience with his friends and colleagues diagnosed with , assuring the patients, advocates, physicians, and industry at Congressional Reception that "We are going to take all of this pain and turn it into something positive."
Reply Retweet Like
GT Medical Technologies, Inc. Jul 17
tells GBM patients and their caregivers, "We are with you - we are your wingmen and wingwomen," at the Congressional Reception this evening.
Reply Retweet Like
GT Medical Technologies, Inc. Jul 17
This is a demo of the bioresorbable, conformable GammaTile that is placed along the tumor bed after a recurrent brain tumor is resected. Radiation therapy begins working right away, and without the need for follow-up appointments at a radiation treatment center.
Reply Retweet Like
GT Medical Technologies, Inc. Jul 17
Along with other industry and government leaders, we will be attending the Congressional Reception at the US Capitol to show our support for patients with glioblastoma and share how GammaTile Therapy improves the long-term prognosis of individuals diagnosed with GBM.
Reply Retweet Like
GT Medical Technologies, Inc. Jul 17
Join us in commemorating . Today, we honor those who have been impacted by and support the progress that has been made against GBM. offers patients with recurrent GBMs and other brain tumors a new option. Learn more at
Reply Retweet Like
GT Medical Technologies, Inc. retweeted
National Brain Tumor Society Jul 16
is the most common, complex and treatment-resistant type of brain cancer. That’s why we’re thankful that the United States Senate has officially designated tomorrow, July 17, as Glioblastoma Awareness Day
Reply Retweet Like
GT Medical Technologies, Inc. Jul 10
Looking forward to seeing you at ! Did you know that GammaTile Therapy, a technology developed in , is 1 of only 7 products FDA-cleared or approved for treating GBMs in the past 30 years? Please visit us at our Tempe HQ when you're in town!
Reply Retweet Like
GT Medical Technologies, Inc. Jul 10
Looking forward to seeing you at ! Did you know that GammaTile Therapy, a technology developed in , is 1 of only 7 products FDA-cleared or approved for treating GBMs in the past 30 years? Please visit us at our Tempe HQ when you're in town!
Reply Retweet Like
GT Medical Technologies, Inc. retweeted
AZ Bioscience News Jun 18
Congratulations to Bioscience Entrepreneur co-founder & CTO David Brachman, recipient of the American Brachytherapy Society’s “Judith Stitt Best Abstract Award” for his abstract on Gamma Tile therapy.
Reply Retweet Like
GT Medical Technologies, Inc. Jun 17
“These data further support the safety profile and efficacy of GammaTile Therapy for patients with brain tumors,” said Dr. Brachman on his abstract that was awarded the Judith Stitt Best Abstract Award at
Reply Retweet Like
GT Medical Technologies, Inc. Jun 14
Congratulations to Dr. David Brachman for being awarded the Judith Stitt Best Abstract Award for his abstract on Therapy at
Reply Retweet Like
GT Medical Technologies, Inc. Jun 13
We are excited to meet you at ! Stop by Table F to learn more about how Therapy combines the tried and true benefits of brachytherapy with significant improvements to delivery, dosing, and safety profile.
Reply Retweet Like
GT Medical Technologies, Inc. Jun 12
Watch last night's episode of Arizona Horizon with Dr. David Brachman on to learn more about Therapy, the genesis of GT MedTech, and the benefits of GammaTile for patients with recurrent brain tumors.
Reply Retweet Like
GT Medical Technologies, Inc. Jun 12
We are headed to ! Tomorrow, stop by Table F to learn more about Therapy, a novel approach to recurrent brain tumor treatment that targets tumor cells while preserving brain tissue.
Reply Retweet Like
GT Medical Technologies, Inc. retweeted
Arizona PBS Jun 11
A -based has created a new way to target recurrent brain tumors – much like the one that took late Sen. McCain’s life. Dr. David Brahman of discusses this unique radiation therapy that extends overall survival for some patients. Tune in to at 5:30 p.m.
Reply Retweet Like
GT Medical Technologies, Inc. Jun 11
Tune into Arizona Horizon on tonight at 5:30 PM to hear Dr. David Brachman, Co-Founder and Chief Technology Officer of , discuss how Therapy improves the lives of patients with recurrent brain tumors.
Reply Retweet Like